These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Clinical utility of probiotics in inflammatory bowel disease. Cain AM; Karpa KD Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946 [TBL] [Abstract][Full Text] [Related]
26. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Hedin C; Whelan K; Lindsay JO Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082 [TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson's disease model. Perez Visñuk D; Savoy de Giori G; LeBlanc JG; de Moreno de LeBlanc A Nutrition; 2020; 79-80():110995. PubMed ID: 32977125 [TBL] [Abstract][Full Text] [Related]
29. A review of complementary and alternative approaches to immunomodulation. Clarke JO; Mullin GE Nutr Clin Pract; 2008 Feb; 23(1):49-62. PubMed ID: 18203964 [TBL] [Abstract][Full Text] [Related]
30. A probiotic combination attenuates experimental colitis through inhibition of innate cytokine production. Kim MS; Byun JS; Yoon YS; Yum DY; Chung MJ; Lee JC Benef Microbes; 2017 Apr; 8(2):231-241. PubMed ID: 28008786 [TBL] [Abstract][Full Text] [Related]
31. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics. Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447 [TBL] [Abstract][Full Text] [Related]
32. Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL-10 in a colorectal cancer mouse model. Del Carmen S; de Moreno de LeBlanc A; Levit R; Azevedo V; Langella P; Bermúdez-Humarán LG; LeBlanc JG Int Immunopharmacol; 2017 Jan; 42():122-129. PubMed ID: 27912148 [TBL] [Abstract][Full Text] [Related]
33. Lactic acid bacteria as a cell factory for riboflavin production. Thakur K; Tomar SK; De S Microb Biotechnol; 2016 Jul; 9(4):441-51. PubMed ID: 26686515 [TBL] [Abstract][Full Text] [Related]
34. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384 [TBL] [Abstract][Full Text] [Related]
35. A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease. Kanai T; Mikami Y; Hayashi A J Gastroenterol; 2015 Sep; 50(9):928-39. PubMed ID: 25940150 [TBL] [Abstract][Full Text] [Related]
36. Complete genome sequence of Lactobacillus plantarum LZ227, a potential probiotic strain producing B-group vitamins. Li P; Zhou Q; Gu Q J Biotechnol; 2016 Sep; 234():66-70. PubMed ID: 27480344 [TBL] [Abstract][Full Text] [Related]
37. The therapeutic effect of probiotic bacteria on gastrointestinal diseases. Sarowska J; Choroszy-Król I; Regulska-Ilow B; Frej-Mądrzak M; Jama-Kmiecik A Adv Clin Exp Med; 2013; 22(5):759-66. PubMed ID: 24285463 [TBL] [Abstract][Full Text] [Related]
38. Microecology as a target for therapeutic intervention in inflammatory bowel disease. Guarner F IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066 [TBL] [Abstract][Full Text] [Related]
39. [Probiotics have a limited role in the treatment of inflammatory bowel disease]. Dieleman L; Hoentjen F Ned Tijdschr Geneeskd; 2012; 156(40):A5206. PubMed ID: 23031240 [TBL] [Abstract][Full Text] [Related]
40. Probiotics in inflammatory bowel disease--therapeutic rationale and role. Shanahan F Adv Drug Deliv Rev; 2004 Apr; 56(6):809-18. PubMed ID: 15063591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]